Results 81 to 90 of about 27,698 (224)

Inhibition of angiotensin-converting enzyme by captopril: A novel approach to reduce ischemia-reperfusion injury after lung transplantation [PDF]

, 2000
Stefan Fischer, Alexandra A. MacLean, Mingyao Liu, Baljit Kalirai, Shaf Keshavjee   +4 more
openalex   +1 more source

Computational Insights into Captopril’s Inhibitory Potential Against MMP9 and LCN2 in Bladder Cancer: Implications for Therapeutic Application

Cancer Informatics
Objectives: Captopril is a commonly used therapeutic agent in the management of renovascular hypertension (high blood pressure), congestive heart failure, left ventricular dysfunction following myocardial infarction, and nephropathy.
Sanjida Kabir Annana, Jannatul Ferdoush, Farzia Lamia, Ayan Roy, Pallab Kar, Monisha Nandi, Maliha Kabir, Ayan Saha   +7 more
doaj   +1 more source

Captopril and lisinopril suppress production of interleukin-12 by human peripheral blood mononuclear cells [PDF]

, 1998
Cris S. Constantinescu, David B. P. Goodman, Elvira Ventura   +2 more
openalex   +1 more source

Preparation and Characterization of Cerium (III) Doped Captopril Nanoparticles and Study of their Photoluminescence Properties

, 2016
Shahriar Ghamami, Sanaz Kazemzade Anari, Masome Bakhshi, Amir Lashgari, Guillermo Salgado‐Morán, Daniel Glossman‐Mitnik   +5 more
openalex   +2 more sources

Effects of captopril on the left ventricular compliance and fibrosis after nontransmural infarction in rat [PDF]

, 1996
Byung‐Hee Oh, Seil Oh, Kihoon Han, Hyo‐Soo Kim, Cheol‐Ho Kim, Myoung-Mook Lee, Young-Bae Park, Yun-Shik Choi, Jung‐Don Seo, Young-Woo Lee, Hee Chan Kim   +10 more
openalex   +1 more source

Effects of captopril on expression of MMP-2, 3 and TIMP-2, 3 in rat hepatic fibrosis

, 2003
Qian Li, Guiying Zhang, Xinhua Li, Meihua Xu   +3 more
openalex   +1 more source

A very rare complication of sublingual captopril

, 2020
Adem Adar, Orhan Önalan, Habibullah Aktaş, Süha Ertuğrul, Fahri Çakan   +4 more
openalex   +1 more source

Spectrophotometric method for the determination of Captopril in pharmaceutical formulations

, 2013
Baghdad Science Journal
openalex   +2 more sources

Kinetics of cardiac and vascular remodeling by spontaneously hypertensive rats after discontinuation of long-term captopril treatment

Brazilian Journal of Medical and Biological Research, 2010
Angiotensin-converting enzyme inhibitors reduce blood pressure and attenuate cardiac and vascular remodeling in hypertension. However, the kinetics of remodeling after discontinuation of the long-term use of these drugs are unknown.
W.A. Rocha, W. Lunz, M.P. Baldo, E.B. Pimentel, E.M. Dantas, S.L. Rodrigues, J.G. Mill   +6 more
doaj  

Captopril usage in determining myocardial viability on a nuclear ventriculography

Revista Cubana de Cardiología y Cirugía Cardiovascular, 2014
In order to diagnose myocardial viability in infarct patients with depressed ventricular function, we used the vasodilator effect of Captopril in a nuclear ventriculography.
Amalia Peix González, David García Barreto, Felizardo Ponce Vicente, Adlin López Díaz, Ana Ma. Maltas Pineda   +4 more
doaj